MiMedx Group, Inc. announced that it has finalized a settlement with the Securities and Exchange Commission (the “SEC”), resolving a previously disclosed investigation into the Company’s financial accounting practices.

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that Luis A. Aguilar has notified the Company of his resignation from the Board of Directors. The Board expresses its appreciation for his service.